These neurotrophin effects are mediated when binding to the cell-surface receptors like tropomyosin-related kinase receptor/tropomyosin receptor kinase A (TrkA) and p75 neurotrophin receptor (NGFR/p75NTR), of which TrkA is mainly expressed on the cancer cell surface [17]. Here, NTRK1 is linked to cancer.